What are BTK Degraders? with Joanna Rhodes, MD - HealthTree for Chronic Lymphocytic Leukemia
[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

What are BTK Degraders? with Joanna Rhodes, MD

What are BTK Degraders? with Joanna Rhodes, MD  image

What are BTK Degraders? with Joanna Rhodes, MD

event Apr 01, 2025 / 10:00AM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

This HealthTree for CLL podcast aims to inform listeners about a new class of therapeutics being developed known as BTK degraders. Joining us for this episode is Dr. Joanna Rhodes the head of Lymphoma at RWJ Barnabas at Rutgers University.

 

Schedule & Agenda

The panelist Dalton Bean
11:00 PM
Introduction
Dalton Bean

Dalton introduces the agenda of the event and featured speaker Dr. Joanna Rhodes

The panelist Joanna Rhodes, MD
11:05 PM
Interview
Joanna Rhodes, MD

Speakers & Moderators

The panelist Dalton Bean
Dalton Bean
Lehi, UT

Dalton joined HealthTree in 2024 as the CLL and MF Education Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.

Read Bio
The panelist Joanna Rhodes, MD
Joanna Rhodes, MD

Dr. Joanna M. Rhodes is the Director of the Lymphoma Program at Rutgers Cancer Institute, Systems Lead for Lymphoma for RWJ Barnabas, and an Assistant Professor at the Rutgers New Jersey Medical School. She completed her medical degree at Stony Brook University School of Medicine and went on to complete her residency in Internal Medicine at New York Presbyterian- Weill Cornell. She did her fellowship at the University of Pennsylvania and also received a Master of Science in Clinical Epidemiology. She is board certified in Internal Medicine, hematology and medical oncology. Her clinical interests are in chronic lymphocytic leukemia and other lymphomas. Her research interests include the development of novel therapies for CLL and lymphomas as well as the pharmacoepidemiology of targeted agents in lymphoma and toxicity management strategies.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Disease Progression and Relapsed/Refractory group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Burkitt Lymphoma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.